FCHI8,141.92-0.19%
GDAXI24,083.53-0.19%
DJI49,164.94-0.13%
XLE56.940.11%
STOXX50E5,860.32-0.39%
XLF51.740.62%
FTSE10,321.09-0.56%
IXIC24,884.780.19%
RUT2,786.12-0.03%
GSPC7,173.920.12%
Temp29.3°C
UV12.4
Feels33.3°C
Humidity66%
Wind13 km/h
Air QualityAQI 1
Cloud Cover25%
Rain0%
Sunrise06:00 AM
Sunset06:47 PM
Time1:04 PM
8-KSEC Filing

BDX Executive Vice President Byrd to Retire, Successor Planned

8-K filed on April 9, 2026

April 9, 2026 at 12:00 AM

🧾 What This Document Is

This is a Form 8-K, a "current report" that companies must file with the SEC to announce major events that shareholders should know about. Think of it as a quick, important news alert. This specific report has two main announcements: an executive retirement and a related press release.

🏢 What The Company Does

👉 In simple terms, Becton, Dickinson & Company (BDX) is a massive global medical technology company. They make a wide range of products for healthcare, from syringes and medical supplies to complex diagnostic systems and lab equipment. They essentially create the tools doctors, nurses, and scientists use every day.

👔 The Key Departure

The core news here is a leadership change. Richard E. Byrd, who is an Executive Vice President and the President of the Interventional segment, informed the company on April 6, 2026, that he plans to retire.

  • His Role: He leads the Interventional segment, a major part of BD's business focused on areas like vascular therapy and surgical solutions.
  • Timeline: He will stay in his job through June 2026.
  • The Plan: BD has stated they intend to name a successor before he leaves.

Why it matters: The departure of a segment president is a significant event. It creates a transition period and signals a change in leadership for a key business unit, which investors will watch closely.

📢 The Public Announcement

A few days later, on April 9, 2026, BD officially told the public about this retirement by issuing a press release. That press release is attached to this filing as Exhibit 99.1. The company isn't just filing a dry report; they are actively communicating this change to the market.

⚖️ The Regulatory Rule Followed

This section, called Regulation FD (Fair Disclosure), is important but technical. It's essentially a rule that says when a company shares material (important) information with some people, they must also share it with everyone at the same time. By attaching the press release here, BD is ensuring this executive news is fairly and publicly disclosed.

🔮 What's Next

The immediate next step is clear: BD will search for and appoint a new leader for its Interventional segment. The transition is scheduled to be completed by the end of June 2026. Investors will be looking for who gets named and how that person's strategy might shape this part of the business.

💼 Company Contact Info

If you had questions, here is the official contact for BD:

  • Address: 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880
  • Phone: (201) 847-6800

🧠 The Analogy

This filing is like a major sports team announcing that one of its star coaches—head of a key department like defense—will be retiring at the end of the season. The team is letting fans and analysts know now, has a plan to find a replacement, and is making sure the news is shared equally with everyone, from season-ticket holders to the media.

🧩 Final Takeaway

BDX is proactively managing a leadership transition. An executive vice president overseeing an important business segment is retiring in mid-2026, and the company has a public plan to find his replacement before he leaves. This is a routine but notable change in the C-suite.